Back to Stock Analysis
AbbVie$ABBV
11 research articles
By following, you request company-alert emails. Manage or stop them anytime in your account. Privacy.
Research Articles
Dividend Informer Q2 2024 Update: AbbVie
AbbVie ($ABBV) • By Dividend Informer • 2024-08-06
Dividend Informer Q3 2024 Update: AbbVie
AbbVie ($ABBV) • By Dividend Informer • 2024-11-01
Dividend Informer Q4 2024 Update: AbbVie
AbbVie ($ABBV) • By Dividend Informer • 2025-02-06
Dividend Informer Q1 2025 Update: AbbVie
AbbVie ($ABBV) • By Dividend Informer • 2025-05-01
Dividend Informer Q4 2025 Update: AbbVie
AbbVie ($ABBV) • By Dividend Informer • 2026-02-18
Dividend Informer Q1 2026 Update: AbbVie
AbbVie ($ABBV) • By Dividend Informer • 2026-05-08
Dividend Informer NEWS FLASH: AbbVie to Acquire Apogee Therapeutics
AbbVie ($ABBV) • By Dividend Informer • 2026-06-23
Dividend Informer Q2 2026 Update: AbbVie
AbbVie ($ABBV) • By Dividend Informer • 2026-08-05
Stock In The Spotlight: AbbVie Inc.
AbbVie ($ABBV) • By The Investor's Edge • 2020-08-28
AbbVie - An Investor Trifecta
AbbVie ($ABBV) • By The Investor's Edge • 2021-01-27
Deep Dive #8-2023: AbbVie Inc.
AbbVie ($ABBV) • By The Investor's Edge • 2023-04-30